Section I. Introduction.- 1. Introduction: Classification, Terminology, Epidemiology and Etiology of Cutaneous Adverse Drug Reactions.- Section II. Pathomechanisms of Cutaneous Adverse Drug Reactions.- 2. Immunology of Cutaneous Adverse Drug Reactions.- 3. Pharmacogenomics and Cutaneous Adverse Drug Reactions.- 4 Viral Reactivation in Cutaneous Adverse Drug Reactions.- 5. Using Technology to Learn About Immunology of Cutaneous Adverse Drug Reactions.- Section III. Clinical Perspectives of Cutaneous Adverse Drug Reactions.- 6. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Epithelial Necrolysis).- 7. Drug Reaction with Eosinophilia and Systemic Symptoms.- 8. Acute Generalized Exanthematous Pustulosis.- 9. Urticarial Reactions to Drugs.- 10. Dermatological Adverse Events from Cancer Treatments.- 11. Cutaneous Adverse Drug Reactions in Pediatric Population.- 12. Cutaneous Drug Reactions in the Elderly.- 13. Cutaneous Adverse Drug Reactions in Human Immunodeficiency Virus Patients.- 14. Cutaneous Adverse Drug Reactions from Anti-Tuberculosis Treatment.- Section IV. Approach to the Patient with a Cutaneous Adverse Drug Reaction.- 15. Practical Approach to Diagnosis and Management of Cutaneous Adverse Drug Reactions.- 16. Histopathology of Severe Drug Eruptions.- 17. Evaluation of Drug Safety Literature: A Guide for the Practicing Dermatologist.- 18. In vitro and in vivo tests in Cutaneous Adverse Drug Reactions.- 19. Pharmacovigilance of Cutaneous Adverse Drug Reactions.- Section V. Epilogue.- 20. Future Directions and Unmet Research Needs in Cutaneous Adverse Drug Reactions.- 21. Atlas of Cutaneous Adverse Drug Reactions.